Australian universities generated $336 million in commercialisation revenue in 2025, up 39% year on year, according to Knowledge Commercialisation Australasia. New Zealand added NZ$189 million, up 35%. The sector created 102 new companies and closed 766 licensing deals.
The numbers look strong until you factor in what just disappeared from the pipeline. The federal government redirected more than $800 million in uncommitted funding from Australia's Economic Accelerator and paused new applications to the Industry Growth Program. That creates a capital gap precisely where most university spinouts need it: between proof of concept and investable scale.
Conry Tech illustrates the problem. The company spent six years developing an air conditioning system that cuts energy consumption by 70%. They have a working prototype. They applied for $5 million through the Industry Growth Program in late 2025. Still waiting. Now they are talking to investors in Asia and the US, who may require the company to relocate as a condition of funding.
"Australia's competitive advantage is our ability to do research and development," co-founder Sam Ringwaldt told SmartCompany. "We're left in this no man's land of no capital." He specifically cited the $2 million to $10 million range as underfunded.
The Go8 universities remain the dominant commercialisation players. They generated $95.5 million in 2020, more than double CSIRO's $43.3 million. The University of Queensland's UniQuest arm has launched more than 100 startups and facilitated over 1,000 industry partnerships, with portfolio companies including Spinifex Pharmaceuticals and Microba.
For context: La Trobe runs commercialisation with five full-time staff, generates roughly $400,000 annually from commercialisation against $90 million in total research income, and is planning a $1 million annual proof-of-concept fund plus a $15 million concept-development fund over five years. That ratio of commercialisation revenue to research spend is typical across the sector.
The sector created more than 400 companies from public research with an aggregate value of about $1.5 billion, per the same KCA data. Growth is real. The funding gap is also real. Startups that need capital between university seed programs and Series A are looking offshore, which means the IP may follow the money.